-
1 Comment
Innovation Medical Management Co., Ltd is currently in a long term uptrend where the price is trading 2.7% above its 200 day moving average.
From a valuation standpoint, the stock is 16.4% cheaper than other stocks from the Consumer Cyclical sector with a price to sales ratio of 4.3.
Innovation Medical Management Co., Ltd's total revenue rose by 33.5% to $207M since the same quarter in the previous year.
Its net income has increased by 100.4% to $4M since the same quarter in the previous year.
Finally, its free cash flow grew by 243.8% to $42M since the same quarter in the previous year.
Based on the above factors, Innovation Medical Management Co., Ltd gets an overall score of 5/5.
| Sector | Consumer Cyclical |
|---|---|
| Industry | Luxury Goods |
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE1000007J6 |
| Dividend Yield | None |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | 0.54 |
Innovative Medical Management Co.,Ltd. engages in the medical services business in China. The company owns and operates Jianhua Hospital, Kanghua Hospital, Futian Hospital, and Mingzhu Hospital. Its medical services include outpatient, inpatient, and medical examination. The company was formerly known as Qianzu Pearl Group Co., Ltd. and changed its name to Innovative Medical Management Co.,Ltd. in June 2016. Innovative Medical Management Co.,Ltd. was founded in 1997 and is headquartered in Zhuji, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002173.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
